Back

SLC4A3 anion exchanger mutations associated to sudden death : short or long QT syndrome?

1 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Clinical and experimental arrhythmia treatments Ion Channel Disorders ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Sami Benbekhti

Montpellier (France)

8 More presentations in this session

Presentation thumbnail
Efficacy and safety of ultrasound guided stellate ganglion block: developing new clinical indications beyond electrical storm
Doctor A. Morena (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Atrial and ventricular arrhythmias in young, lifelong and retired elite endurance athletes
Doctor P. D'Ambrosio (Fitzroy, AU)
Abstract Slides Video
Presentation thumbnail
Analysis of safety and outcome of use of NOAC in intracardiac thrombi over warfarin
Doctor O. Al-assaf (Dubai, AE)
Abstract Slides Video
Presentation thumbnail
Amiodarone-related thyroid dysfunction and associated outcomes in patients with heart failure - a matched case-control study
Doctor S. Ali (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Association between preprocedural thromboembolic or bleeding events under oral anticoagulation therapy and mid-term outcomes after percutaneous left atrial appendage closure
Doctor H. Sumiyoshi (Kamogawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical and experimental arrhythmia treatments

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
A novel variant of SLC4A3 gene mutation associated with familiart short-qt syndrome, sudden death and epilepsy
12 April 2026
thumbnail
Congress Presentation
Characterization of the cardiac and non-cardiac phenotype associated with genetic variants in KCNJ2
27 August 2023
thumbnail
Congress Presentation
Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.
1 September 2024
thumbnail
Congress Presentation
A novel synonymous SGCA variant associated with arrhythmogenic cardiomyopathy in limb-girdle muscular dystrophy type 3
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources